Glutamate receptors in the substantia nigra of Parkinson's disease brains.
about
Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humansIdentification of a subunit-specific antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate/kainate receptor channels.A functionally relevant and long-term model of deep brain stimulation of the rat subthalamic nucleus: advantages and considerations.The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis.Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons.Nitric oxide enhances MPP(+) inhibition of complex I.Catecholamine neuron groups in rat brain slices differ in their susceptibility to excitatory amino acid induced dendritic degeneration.Vulnerability to glutamate toxicity of dopaminergic neurons is dependent on endogenous dopamine and MAPK activation.Taurine Chloramine Prevents Neuronal HT22 Cell Damage Through Nrf2-Related Heme Oxygenase-1.Spatial distribution of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon.Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms.Association between the low threshold calcium spike and activation of NMDA receptors in guinea-pig substantia nigra pars compacta neurons.Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain.Glutamine synthetase actiity in patients with Parkinson's disease
P2860
Q28286171-480CFF60-B9DC-463C-B3CF-8B9ED9AE6EC9Q36063415-BC6DD366-3D80-4720-B8F9-37E3C73118EFQ37805651-F7A1FB1A-7C24-443E-A312-EDFA2958482BQ42446235-18B241E6-714A-435E-815C-FD6A0B3A8001Q42450443-236E955C-6E20-44C9-B11F-5259EFDFAF61Q43719516-AEFCF01C-F4BC-4452-A363-AD72209C25D6Q44865019-A8F57386-E11A-4AF2-8D07-2451EC12929AQ46003845-7E203804-639B-4B67-8510-428DD6D7B4C7Q46315180-AD9D67D4-2BEF-45FB-B3F0-6A4D8EA30F91Q46619147-3830077E-1EA6-4402-885E-6FF78A730C8EQ47994663-39BCFB65-41A7-460D-B91B-3402D755AF12Q48387368-0BF2937C-80DC-4856-8944-2F98AFBE1B8DQ48483647-842FD751-4B55-49BE-8E6F-A4AEE2A48C7BQ57623669-AFC966ED-D282-4C4B-B206-214BAAD7D398
P2860
Glutamate receptors in the substantia nigra of Parkinson's disease brains.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Glutamate receptors in the substantia nigra of Parkinson's disease brains.
@en
Glutamate receptors in the substantia nigra of Parkinson's disease brains.
@nl
type
label
Glutamate receptors in the substantia nigra of Parkinson's disease brains.
@en
Glutamate receptors in the substantia nigra of Parkinson's disease brains.
@nl
prefLabel
Glutamate receptors in the substantia nigra of Parkinson's disease brains.
@en
Glutamate receptors in the substantia nigra of Parkinson's disease brains.
@nl
P2093
P356
P1433
P1476
Glutamate receptors in the substantia nigra of Parkinson's disease brains.
@en
P2093
Difazio MC
Hollingsworth Z
Penney JB Jr
P304
P356
10.1212/WNL.42.2.402
P407
P577
1992-02-01T00:00:00Z